/* Pinterest verifcation tag */

Latest News

Ocrelizumab approved for funding

October 7, 2019 | Advocacy, Life with MS, Treatments

Media Release – 7 October 2019 Hundreds with Multiple Sclerosis ‘Abandoned’ due to Pharmac Drug Access Criteria There’s concern that a Pharmac decision to fund the drug Ocrelizumab (Ocrevus) for certain patients with multiple sclerosis from December 1st will still […]